Nod for Sputnik Light Phase-III trials
The subject expert committee that advises the Drugs Controller General of India (DCGI) has recommended that Dr Reddy’s Laboratories, the Indian partner of Russian Direct Investment Fund, conduct a Phase III bridging study in India for Sputnik Light, the single dose version of Russian Covid-19 vaccine Sputnik V.
Admin
0
7
The subject expert committee that advises the Drugs Controller General of India (DCGI) has recommended that Dr Reddy’s Laboratories, the Indian partner of Russian Direct Investment Fund, conduct a Phase III bridging study in India for Sputnik Light, the single dose version of Russian Covid-19 vaccine Sputnik V. 
